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Dear Graham,  
 
Many thanks for the three constructive reports on our ms.  I am now submitting a revised 
manuscript and illustrations.  Below we give our responses to the reviewers, detailing changes we 
have made, addressing most of the reviewers’ suggestions, and pointing out where it has not been 
practicable.  In the revised manuscript, altered sections of text are marked in yellow. 
 
Best wishes 
John 
 
 
 
Reviewer #1: This is an interesting manuscript on spatiotemporal expression pattern of 
hemangioblastic foci in the 1st trimester placenta. Although the reviewer appreciates the 
remarkable descriptive effort of the authors to characterize blood cell and blood vessel development 
in early placental tissue some aspects of the work need - in his opinion -clarification. 
 
In reviewer's opinion following questions remain unanswered: 
 
1. Do the HAF cells originate from common bipotent progenitor (hemangioblas?) or different, 
independently fated mesodermal progenitors or even hemogenic endothelium? 
 
2. Since HAF possibly consist of mixed cell population, further characterisation (using specific 
markers including FLK-1, Gata-1, cKIt, VE-cadherin or Runx 1) might provide more detailed 
information in regard to their origin. 
 
3. Do the HAF cells originate from chorionic or allantoic mesoderm? 
 
4. Are HAF cells involved in primitive or definitive hematopoiesis? 
 
We thank the reviewer for these insightful comments.  We agree that important questions 
regarding the origins and fates available to cells in placental HAFs remain unanswered at this stage.  
Especially given the restrictions associated with working in human, we believe that answers to 1 and 
4 will only be gained by carrying out in vitro studies, ideally on very early tissues which are a scarce 
resource. We aim to develop methods for cell isolation and propagation, but this will take time.   
 
On point 2, several of the markers listed are expressed not only on hemangioblastic cells but 
also in other placental populations, limiting their use in whole mount imaging studies.  However we 
have added a new stem cell marker, CD41, to the data presented. Its presence in cells emerging from 
HAFs suggests that non-erythroid fates may be accessible.  We have also added some colocalisation 
data that allow a more detailed insight into the segregation of CD34 (stem cells and endothelial cells) 
Response to Reviewers
from CD235a (erythroid cells). This has required the addition of a new coauthor as well as a larger 
sample set.  
 
As for point 3, there is evidence of hematopoiesis in the human yolk sac between 16 and 19 
days gestation (Kelemen e et al 1979. Atlas of human hematopoietic development. Springer, Berlin) 
and it has been identified by one of us in the human yolk sac between 6 and 10 weeks (Jones CJ and 
Jauniaux E 1995. Micron 26: 145). It is therefore possible that it occurs in the two sites 
simultaneously. 
 
 
5. The author's proposal that HAFS may act as oxygen reservoir during early placental 
development is exciting but not sufficiently supported by the data presented. 
 
We agree this is speculative and have changed the wording in the abstract and text to make 
it clear. 
 
 
Reviewer #2: This manuscript describes the identification and characterisation of what the authors 
designate as Hemangioblastic foci (HAF).  Understanding the processes of vasculogenesis and 
hematopoeisis in the placenta is both challenging and important.  The main challenge is obtaining 
suitable well preserved specimens.  The authors in this study have overcome this by using some 
newly collected material and archival material.  By the nature of such specimens the experimental 
design is quite constrained and essentially limited to descriptive histological methods.  That said, this 
study is well conducted and my comments will only require modest changes to the manuscript. 
 
We thank this referee for her or his positive remarks. 
 
1 In the abstract (line 40) the authors "propose" that the HAFs (although in the discussion, 
line 267 that it is the erythrocytes) act as an oxygen reservoir.  Thus is all rather 
speculative and stated a little too strongly.  While it is a reasonable speculation I would 
suggest removing this from the abstract. 
 
See response to referee 1 point 5. We have tried to be more precise in the revised text. 
 
2 The annotation of the figures needs improving.  The addition of arrows and indicating in 
the legend what the arrows that are present are highlighting.  At present this is 
inconsistent. 
We’ve added arrows and asterisks to Figure 2,3,6, annotated the new supplementary 
figures, and alluded to the corresponding features in the legends. 
 
3 In the methods section the specific biotinylated lectins used are not described. 
Now addressed. 
 
4 Line 140, the type, not just the degree of glycosylation could also have changed. 
We agree, now addressed. 
 
5 The section on the proposed role of the hofbauer cells (around line 218) is somewhat 
speculative and needs to be shortened and phrased with less certainty.  The results 
show very few examples of staining for macrophages and this is in contrast to the 
disproportionately long section in the discussion. 
We have added some later tissue specimens, extending the study to 11 weeks, and added 
a new supplementary figure that describes the occurrence of Hofbauer cells in the vicinity 
of extravascular erythrocytes.   
6 Lines 255-257.  This sentence is unclear and should be reworded. 
Done. 
 
7 The Centre for Trophoblast Research (CTR, fig 2) needs to be defined in the methods.  
Done.  
 
8 Fig 6 - the legend states panels C and d are serial sections.  This is not the case in the 
figure. 
This error has been corrected to A and B. 
 
 
 
Reviewer #3: Aplin and colleagues describe hemangioblastic foci in human first trimester placenta.  
The study appears to have been well done using conventional methods. 
 
There are, however, some minor points that need to be addressed. 
 
In Fig. 2, addition of arrows (or some other labeling symbol) to indicate the features mentioned in 
the text are needed. 
Done 
 
In Fig. 3A-C, addition of arrows is needed. 
Done  
 
In the legend for Fig. 5, more information is needed for readers to understand what is being shown 
is needed. 
Arrows and asterisks now supplied along with some descriptive text in the legend. 
 
In Fig. 5, the structures of interest should be noted.  Also it is not clear why grey scale images are 
mixed with color images. 
Capture was with a monochrome camera, the grey scale images are shown so readers 
understand that C and D are false colour images. 
 
The legend for Fig. 6 is so brief that it provides little information.  For example, what are the labeled 
structures?  Again, labeling the figures would be helpful. 
Labels added. 
 
In the Discussion, the authors point out that improper fixation may have been a problem in some 
studies related to this topic.  Surprisingly, the fixation conditions for this study were not given 
(except for the glutaraldehyde used for the resin embedded specimens). 
Now addressed. 
 
In the Abstract (Methods), it is stated that thin sections were used.  Generally the term "thin 
section" is used to describe resin embedded samples that are sectioned at 50-100 nm for 
examination by transmission electron microscopy.  The wording should be modified. 
Now given as semi-thin. 
 
While the sources of antibodies and their concentrations were given, this is not the case for the 
lectins.  This information is needed. 
Now given. 
 
What are the binding partners for the two lectins used in this study?  Why were these lectins used 
and not some other lectins. 
Explanation provided. 
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ABSTRACT 16 
Introduction: The human placenta is a site of both hematopoiesis and vasculogenesis.  There are 17 
reports of hemangioblastic foci (HAF) in the first trimester placenta, but little published information 18 
about their spatiotemporal incidence.   19 
Methods: We have used semi-thin sections and whole mount staining techniques on archival early 20 
pregnancy hysterectomy material as well as freshly-collected termination tissue.  21 
Results: We report a description of the distribution of HAF, their gestational profile, and some 22 
characteristics of the constituent cells.  We show crypt-shaped HAF are present in villi at different 23 
levels from 4-11 weeks and in the chorionic plate from 4-9 weeks.   In the villous placenta, the foci 24 
often approach closely at one end to the trophoblast basement membrane.  Morphologically they 25 
show remarkable similarity to those found in the yolk sac at similar stages.  In some crypts, all cells 26 
are CD34+, but CD34 and nestin progressively segregate into the endothelial lineage.  Brachyury is 27 
present in less differentiated cells.  The erythroid lineage is dominant, as shown by the widespread 28 
expression of CD235a/glycophorin and characteristic erythroid morphologies, indicating various 29 
degrees of differentiation.  However, CD41 is also present in non-endothelial cells.  Initially a 30 
discontinuous UEA-1/CD31-positive endothelium forms at the periphery of the foci.  These cells 31 
appear to become integrated into the developing vasculogenic/angiogenic vessel network.  We also 32 
demonstrate that, independent of HAF, vasculogenesis occurs near the tips of growing villi during 33 
the first trimester. 34 
Discussion: We suggest HAF interface with the developing vascular network, producing 35 
communication channels that allow erythrocytes to enter the placental-embryonic circulation.  We 36 
speculate that the erythroid cells act as oxygen reservoirs during the period before flow of maternal 37 
blood through the intervillous space of the placenta, allowing a slow feed of oxygen-rich cells to the 38 
developing embryo. 39 
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HAF distribution in mid first trimester  
Graphical Abstract
Highlights 
Hematopoiesis occurs in the early human placenta. 
We identify hemangioblastic foci distributed randomly through the villous tree and chorionic plate in 
placenta up to 9-10 weeks.  
These are mainly sites of erythropoiesis, surrounded by a progressively developing endothelium. 
We propose that oxygen-loaded red cells are released gradually from these sites as the embryonic 
circulation spreads through the chorionic plate and into distal regions of the villous tree. 
We show that vasculogenesis continues during first trimester at growing villous tips. Such sites are 
unrelated to hemangioblastic foci, suggesting two distinct endothelial lineages. 
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ABSTRACT 16 
Introduction: The human placenta is a site of both hematopoiesis and vasculogenesis.  There are 17 
reports of hemangioblastic foci (HAF) in the first trimester placenta, but little published information 18 
about their spatiotemporal incidence.   19 
Methods: We have used semi-thin sections and whole mount staining techniques on archival early 20 
pregnancy hysterectomy material as well as freshly-collected termination tissue.  21 
Results: We report a description of the distribution of HAF, their gestational profile, and some 22 
characteristics of the constituent cells.  We show crypt-shaped HAF are present in villi at different 23 
levels from 4-11 weeks and in the chorionic plate from 4-9 weeks.   In the villous placenta, the foci 24 
often approach closely at one end to the trophoblast basement membrane.  Morphologically they 25 
show remarkable similarity to those found in the yolk sac at similar stages.  In some crypts, all cells 26 
are CD34+, but CD34 and nestin progressively segregate into the endothelial lineage.  Brachyury is 27 
present in less differentiated cells.  The erythroid lineage is dominant, as shown by the widespread 28 
expression of CD235a/glycophorin and characteristic erythroid morphologies, indicating various 29 
degrees of differentiation.  However, CD41 is also present in non-endothelial cells.  Initially a 30 
discontinuous UEA-1/CD31-positive endothelium forms at the periphery of the foci.  These cells 31 
appear to become integrated into the developing vasculogenic/angiogenic vessel network.  We also 32 
demonstrate that, independent of HAF, vasculogenesis occurs near the tips of growing villi during 33 
the first trimester. 34 
Discussion: We suggest HAF interface with the developing vascular network, producing 35 
communication channels that allow erythrocytes to enter the placental-embryonic circulation.  We 36 
speculate that the erythroid cells act as oxygen reservoirs during the period before flow of maternal 37 
blood through the intervillous space of the placenta, allowing a slow feed of oxygen-rich cells to the 38 
developing embryo. 39 
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1. Introduction 40 
In the second week of gestation, the outer trophoblast layers of the implanted human embryo are 41 
invested by radial tongues of outgrowing extraembryonic mesenchyme.  From day 14 post 42 
conception, vascular elements begin to form within this layer, comprising cords of endothelial cells 43 
that develop into networks [1-3].   The vascularised mesenchyme forms the stroma of the chorionic 44 
plate and, through progressive outgrowth, the core of the rapidly branching and growing villous 45 
placenta.   The developing placental vascular network connects though the body stalk to the gut, the 46 
developing anterior vascular plexus, the heart and yolk sac [1].   Early in the 5th week of gestation, 47 
when the heart starts beating, the placental vascular network is connected to the embryo and yolk 48 
sac via the chorionic plate and umbilical cord.  49 
Though early studies of the placenta identified vascular elements at these stages [4], limitations in 50 
tissue preservation in the mid 20th century probably obscured hemangioblastic and/or 51 
hematopoietic activity.  This was however suggested in the 1980s [5], and morphological studies as 52 
well as in situ cell marker evidence later emerged to support the idea that hemangioblastic sites are 53 
present in first trimester placenta [6] as well as in the yolk sac [7].  These sites comprise tightly 54 
packed cells, often with recognisable endothelialised margins.  55 
More recently, colony-forming assays conducted with cells isolated from placenta have confirmed 56 
the presence of hematopoietic cells both in the first trimester and later in gestation [8]. The relative 57 
incidence of the various derivative lineages changes, with erythroid precursor cells dominating in the 58 
first 9 weeks though multilineage precursors are also present [9].   Similarly in the mouse, it is clear 59 
that in addition to the yolk sac, the placenta proper is an important hematopoietic tissue [10, 11].    60 
Late in the first trimester, villi regress over the superficial (capsular) aspect of the placenta and the 61 
chorionic plate develops into the avascular chorion laeve.  Studies conducted to date have not 62 
always enjoyed access to well preserved tissue from a spectrum of early gestational ages, and 63 
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generally have not addressed the question of where and when angioblastic sites are found in 64 
relation to the cord insertion.   They have also not clarified the spatial and developmental 65 
relationships between developing vasculogeneic and angiogenic structures and the primitive cell 66 
populations present in putative hemangioblastic foci.  Here we have combined various imaging 67 
methods, including whole mount immunofluorescence and semithin resin sections, in order to throw 68 
light on these and related questions.  69 
 70 
2. Materials and methods 71 
2.1 Tissue  72 
Thirty specimens were analysed from the Manchester early pregnancy tissue bank and 18 from the 73 
Boyd collection at the Centre for Trophoblast Research (CTR) at the University of Cambridge.  74 
Pregnancy termination tissue 4-12 weeks gestation was Carnegie-staged.  Boyd tissues are staged by 75 
crown-rump length; these have been converted to an estimated gestational age to the nearest 76 
week.   Two specimens were also obtained from Dr C Dunk, Toronto.  Tissues were cleaned in 77 
Dulbecco’s Minimal Essential Medium, then fixed in ice-cold 90% methanol overnight before 78 
rehydrating in PBS for whole mount staining.   For immunoperoxidase staining, tissue was fixed in 79 
neutral buffered formalin overnight then washed and processed into paraffin wax.  Efforts were 80 
made to minimise the time between collection and fixation.  A period of <4h gave acceptable 81 
histological preservation.    82 
Whole mount immunofluorescence was carried out essentially as described [12] using directly 83 
conjugated monoclonal antibodies to CD235a (Alexa 488 conjugate, BD Pharmingen 559943, 1/200), 84 
CD41 (Alexa 488 conjugate, MEM-06, AbCam, 1/50) or CD31 (Alexa 647 conjugate, WM59, 85 
BioLegend, San Diego, CA, 1/40).  86 
2.2 Immunohistochemistry 87 
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Sections (6 µm) were heated at 60⁰C for 20 minutes to soften the wax then deparaffinised in 88 
Histoclear (3x 5 minutes) and rehydrated in alcohol (100% ethanol 2x 3 minutes, 70% alcohol 89 
3minutes) then water.  They were microwaved (10min) in citrate buffer pH 6.0 (0.01M), cooled for 90 
20 minutes then endogenous peroxidise activity was blocked using 400ml of methanol containing 91 
1.6ml 1M HCl/litre with 2ml H₂O₂. After rinsing in running water and TBS a 5% bovine serum albumin 92 
protein block was applied. The sections were incubated overnight at 4⁰C with primary antibodies: 93 
monoclonal mouse anti-CD34 (Dako, QBend10, 0.18µg/ml), monoclonal mouse anti-nestin 94 
(10µg/ml), monoclonal mouse anti-CD45 (Dako, 2B11+PD7/26, 7µg/ml), monoclonal mouse anti-95 
CD68 (Dako, PG-M1, 0.4µg/ml), monoclonal rabbit antibody Flk-1 (AbCam, 10C2, 2.5µg/ml), 96 
polyclonal goat anti-brachyury (Santa Cruz, C-19, 4µg/ml, 2µg/ml, 1µg/ml). Controls: mouse IgG 97 
(10µg/ml) for nestin and CD34, mouse IgG (7µm/ml) for CD41, CD45 and CD68, rabbit IgG (2.5µg/ml) 98 
for FLk-1 and TBS (0.125M) for Brachyury. Sections were incubated with secondary antibody: 99 
polyclonal goat anti mouse, polyclonal swine anti rabbit or polyclonal rabbit anti goat followed by 100 
avidin peroxidise (5µg/ml in 0.125 TBS). Peroxidise activity was visualized by application of 101 
diaminobenzidine. The tissue sections were then washed with TBS (0.125M) and counterstained 102 
with hematoxylin. Finally the tissue was dehydrated in alcohol (70% 3minutes, 100% 2x 3 minutes) 103 
and then cleared in histoclear and mounted in DPX. 104 
2.3 Semithin sections and lectin histochemistry 105 
Specimens of placenta of 4, 6, 7 and 8 weeks’ gestation and a 6 week yolk sac were fixed in 2.5% 106 
glutaraldehyde in 0.1M sodium cacodylate buffer pH 7.3 for 4 h, then washed in buffer containing 107 
3mM calcium chloride several times over 24 h before being dehydrated and embedded in TAAB 108 
epoxy resin (TAAB Laboratory Equipment Ltd., Aldermaston, UK). Sections 0.5µm thick were cut and 109 
stained with 1% toluidine blue in 1% borax for 2min on a hotplate at 60˚C then rinsed in water. 110 
Suitable areas were selected for lectin histochemistry and 0.75µm thick sections were mounted on 111 
3-aminopropyltriethoxysilane-coated slides and dried at 50˚C for 48 hours after which they were 112 
6 
 
stained with a panel of 5 lectins as previously described[13]. These were agglutinins from Ulex 113 
europaeus-1, Solarnum tuberosum,  Phytolacca americana, Maackia amurensis (all from Vector 114 
Laboratories Ltd, Peterborough, UK) and Sambucus nigra-1 (E-Y Laboratories, San Mateo, CA, USA) 115 
which bind to fucose (UEA-1), N-acetyl glucosamine oligomers (STA, PAA), α2,3 sialic acid (MAA)and 116 
α2,6-sialic acid (SNA-1).  These lectins were selected from a panel of 25 as a previous study (Jones et 117 
al., 2015) had indicated that  they show binding  to cells of the erythroid lineage. Briefly, after resin 118 
removal with 50% sodium ethoxide, blocking endogenous peroxidase and subjecting the sections to 119 
a brief trypsinization step, sections were stained with 10µg/ml (UEA-1, STA, PAA, MAA) or 50µg/ml 120 
(SNA-1) biotinylated lectin in 0.05M TBS pH 7.6 with 1mM added calcium chloride for 1 hour at 37˚C 121 
then treated with 5 µg/ml avidin peroxidase (Sigma) in 0.125 M TBS, pH 7.6, with 0.347 M sodium 122 
chloride for 1 h at 37°C [14].  Sites of lectin binding were revealed with 0.05% diaminobenzidine 123 
tetrahydrochloride dihydrate (Sigma) in 0.05 M TBS, pH 7.6, and 0.015% hydrogen peroxide (100 124 
volumes) for 5 min at room temperature. Sections were rinsed then lightly counterstained with 125 
Harris’s hematoxylin before mounting in DPX. Images were captured on an Olympus microscope 126 
using Image-ProPlus software (Media Cybernetics, Rockville, MD, USA). 127 
 128 
3. Results 129 
3.1 Morphology and glycosylation of HAF  130 
Flat-mounted unfixed specimens of first trimester villous placenta from the end of the first month 131 
(Figure 1) showed elongated haemoglobin-rich structures, often with bulbous tips approaching close 132 
to, or in direct contact with, the trophoblast basement membrane, though not in all villi.   They 133 
appeared to connect to channels lacking visible haemoglobin that continued along the axis of the 134 
villi.   135 
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Histological wax and semi-thin resin sections of tissue fixed soon after delivery revealed prominent 136 
cleft-shaped or ellipsoid structures in the villous mesenchyme alongside small open vessel profiles 137 
(Figures 2, 3), sometimes called ‘blood islands’, here referred to as hemangioblastic foci (HAF), 138 
interacting closely with basal cytotrophoblast (Figure 3).  In some sections the clefts were seen to 139 
comprise branching networks in villous mesenchyme (Figure 2A).   Simple open endothelialised 140 
vascular channels were also seen, sometimes in close proximity to HAF (Figure 2C), both in villi and 141 
chorionic plate (CP).  Cells packed tightly in the foci showed various stages of erythroid 142 
differentiation, with darker and paler Toluidine blue-staining cytoplasm, indicating alterations in 143 
organelles and cytoplasmic differentiation.  Nuclear profiles varied in diameter, and some cells 144 
showed anuclear profiles (Figure 3B), but serial sectioning revealed that most cells are in fact 145 
nucleated (Supplemental Figure 1) with variation in nuclear size and chromatin density.  146 
Different staining densities reflecting various degrees and types of cytoplasmic glycosylation could 147 
be distinguished in the luminal cells with STA (Figure 3C), MAA and SNA-1, again suggesting cell 148 
differentiation. Most cells bound these lectins at the plasma membrane.   At 4-6 weeks the luminal 149 
cells were often tightly adherent both to the tissue wall, the presumptive endothelium and to one 150 
another.  From 6-8 weeks more clefts were seen containing cells in a looser arrangement, often at 151 
one end of the cleft.   Nucleated erythroblasts and some pyrenocytes were found in stroma 152 
surrounding HAF, often in groups with Hofbauer cells in the near vicinity, and this occurred more at 153 
later stages (9-11 weeks) when the associated vascular spaces contained looser cell aggregates 154 
(Figure 4 F,G).  155 
Within the HAF, endothelial differentiation was evident; UEA-1, which detects endothelial cells in 156 
placenta of all gestations [15], was able to differentiate monolayered endothelial cells exhibiting a 157 
flattened shape at the margins of the clefts (Figure 3E,F).  A few adjacent cells, not yet incorporated 158 
into the presumptive vessel wall, also exhibited UEA-1 staining.  Gaps in the UEA-1-positive layer 159 
persisted in some locations up to 8 weeks, potentially allowing access of cells to or from the 160 
8 
 
surrounding stromal compartment.  Consistent with this, histological staining for microfibrillar 161 
matrix (reticulin) revealed what appeared to be a discontinuous structure around the developing 162 
HAF (Figure 3D). Yolk sac specimens from the same range of gestational ages showed remarkably 163 
similar features (Figure 3G,H,I).  Biochemical heterogeneity of endothelial cells, which may also be 164 
related to the degree of differentiation, was revealed in early pregnancy by variation in binding of 165 
PAA (Figure 3J). 166 
3.2 Gestational profile of HAF 167 
From 4 weeks, HAF were prominent in the chorionic plate (CP) and major villi (Figure 2A and 3D) and 168 
at 6 weeks particularly large foci were seen in stem villi near sites where they branched from the 169 
plate (Figure 4A).  By this time all vessels in the central CP were opening (Figure 4B) while in the 170 
peripheral CP tightly packed HAF were still present (Figure 4C).  Opened lumena were mostly 171 
oriented towards the chorionic plate with residual adherent cells in the opposite pole of the clefts 172 
(Figure 4A,B). More loosely packed profiles were present in some villi from the earliest stage studied 173 
(4 weeks) and they coexisted with close-packed HAF up to 8 weeks, the latter being found 174 
increasingly towards the distal part of the villous tree, especially centrally. Distally and laterally, 175 
away from the central villous placenta, some villi were present that lacked vessel profiles with 176 
lumena of any kind.   177 
From 7 weeks, increasing numbers of discoid, apparently anuclear erythrocytes were present in 178 
villous vessel profiles (Fig 4D, E), and spaces had opened up in many HAF (presumably following cell 179 
displacement) to leave endothelialised vessels with primitive cells still adherent to the walls.  180 
Residual cell clusters could be found up to about 10 weeks but by this time most vessels were open, 181 
though often containing non-adherent nucleated or anuclear erythrocytes. 182 
 183 
 184 
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3.3 Molecular markers: endothelial and erythroid lineages  185 
Immunofluorescence colocalisation was carried out in whole mounted villous tissue using antibodies 186 
to CD31 and CD235a. Strong CD235a (glycophorin A) immunoreactivity was evident in ellipsoid 187 
structures adjacent to the trophoblast (Figure 5A,E).  These foci, interpreted as HAF, were present 188 
from 5 weeks (the earliest tissue studied using this technique) in the CP and at all levels of the villous 189 
tree.  They were absent from some villous branches, apparently at random.    190 
Staining of whole-mounted tissue with antibody to CD31 (Figure 5F, Supplemental Figure 2) or CD34 191 
(Supplemental Figures 3,4) revealed an extensive developing microvascular network present at 5.5 192 
weeks and all later times in both the CP and more or less throughout the villous tree, with 193 
connection between the two.  Though at all times examined the majority of CD31+ or CD34+ cells 194 
were incorporated in the developing anastomosing vascular network,  it was possible to pick out 195 
evidence of vasculogenic activity in the form of double blind-ended cords using whole mount 196 
staining (Supplemental Figures 2-4). Such sites were usually associated with the tips of growing villi. 197 
They were not observed to have any particular association with CD235+ foci, and indeed were seen 198 
in areas from which the latter were absent.   They could be observed as late as 10 weeks.  199 
CD31+ specks could be seen in CD235+ foci (Figure 5F) that did not contain organised CD31+ vascular 200 
structures, and lacked a discrete layer of CD31+ cells at the periphery.  At 8 weeks (and to a lesser 201 
extent at 5 weeks), CD235+ cells could be seen tightly packed in CD31+ vessel channels adjacent to 202 
HAF (Figure 5C).  However, CD235 staining was absent from most areas of the CD31+ villous vascular 203 
network.  By 9 weeks packed CD235+ cells were detected extending farther into the developing 204 
vascular network.  At 10 weeks CD235bright/CD31weak aggregates were uncommon and many more 205 
vascular elements contained CD235+ cells.  Bright field examination confirmed that oxyhemoglobin-206 
positive cells were spread extensively through vascular channels in the villous tree. 207 
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Tightly packed immature cells in cleft-shaped HAF near to the trophoblastic surface were CD34-208 
positive (Figure 6A, 6 weeks), and many were also nestin-positive (Figure 6B, 6 weeks). However, 209 
CD34 and CD235a did not colocalise (Supplemental Fig 5).  At connections into vascular channels, 210 
CD34 (Figure 6C, 5 weeks) and nestin (not shown) both segregate into endothelium, being absent 211 
from the rounded adherent luminal cells, while CD41 staining was present in non-endothelialised 212 
foci as well as in cells feeding into vascular channels (Supplemental Fig 6).  Alpha smooth muscle 213 
actin (not shown) was found on some presumptive endothelial cells as well as on a scattered 214 
population of mesenchymal cells.  FLK1 staining was found in presumptive endothelial cells but not 215 
in most luminal ones (Figure 6D, 5 weeks).  Large rounded nucleated luminal cells, and rounded cells 216 
adherent to endothelium, were brachyury-positive up to at least 8 weeks, consistent with an early 217 
mesenchymal lineage (Figure 6E).  Where gaps were present in the developing endothelium, 218 
brachyury-positive cells could be seen adhering to the tissue surface (Figure 6E).  Very occasionally 219 
CD45+ cells were present in HAF (Figure 6F).  CD68 recognised a prominent population of Hofbauer 220 
cells at all gestational ages. Though often found in adjacent areas of villous stroma (Figures 4F, 6G), 221 
and occasionally in open vessel spaces (Figure 4G), they were not seen amongst the cells in close-222 
packed HAF.  223 
 224 
4. Discussion 225 
Almost all areas of extraembryonic mesenchyme examined in the 4-10 week period were richly 226 
endowed with CD31-positive cords and microvessels, even at the placental periphery, indicating that 227 
investment with vascular elements follows closely the outgrowth of new mesenchyme.  It has never 228 
been delineated how late in gestation vasculogenesis (as opposed to angiogenesis) can occur; here 229 
we examined endothelial markers in whole mounted and serially sectioned  specimens as late as 10 230 
weeks and were able to discern sites where vasculogenesis appeared to be taking place.  Inward 231 
growth from villous tips seems to be guided in a way that allows newly forming cords to join up with 232 
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elements of the existing angiogenic network located more proximally to the CP, possibly facilitated 233 
by Hofbauer cells which, as tissue macrophages, may promote the joining of tip-cells [16] by 234 
providing a bridge and mediating fusion [17].  Hofbauer cells are present in all early stages reported 235 
and are present in extraembryonic mesenchyme in advance of vascularisation [4, 5]. This suggests 236 
that both endothelial and macrophage lineages can arise de novo from mesenchymal precursors, 237 
though it remains possible that cells originating in the yolk sac might colonise the early placenta [18]. 238 
Hofbauer cells were widespread and randomly distributed in villous and chorionic plate tissues 239 
examined in the present study, however they were not observed amongst the close-packed cells in 240 
HAF.  We therefore suggest that the macrophage is not a derivative of the primitive cells found in 241 
HAF.   A majority of endothelial cells and pericytes [19] probably arise directly from primitive 242 
mesenchymal precursor cells; indeed placental mesenchymal stem cells from various times of 243 
gestation have been shown to have the capability to differentiate in vitro into endothelial cells [20].  244 
However, based on the localisation studies herein, we suggest that a second minority population of 245 
endothelial cells arises within HAF, forming a peripheral layer that eventually encases the foci and 246 
joins them to the wider vascular network.   Studies of embryonic stem cells have demonstrated the 247 
existence of a mesoderm-derived precursor for both mesenchymal stem and endothelial cells [21], 248 
and it will be interesting to see if such a cell can be isolated from human placenta.  Lectin 249 
histochemistry has previously shown term endothelial cells to exhibit heterogeneity [22] as seen 250 
here in early pregnancy, and this may reflect differences in surface properties related to cell 251 
adhesion which may be important in release of erythroid cells into the lumen, and/or different 252 
developmental origins. 253 
Early morphologists did not report hemangioblastic sites [2], possibly because if not promptly fixed,  254 
they become difficult to distinguish from red cells densely packed into vascular channels.  Later 255 
higher-quality histological studies discerned these sites and described some of the phenotypic 256 
features of the constituent cells [5, 6]. It has also become clear that mouse placenta is an important 257 
site of hematopoiesis [11]. The combination of bright field examination of fresh, unfixed, flat-258 
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mounted tissue, histochemistry of resin-embedded tissues fixed soon after delivery, and whole-259 
mount double immunofluorescence with antibodies to CD235a (erythroid lineage cells) and CD31, 260 
clearly identifies mesenchymally-located foci.   Consistent CD235a positivity, together with the 261 
presence of cells with few organellar features and dense or condensing nuclear morphology identify 262 
them as predominantly sites of erythroid development, in keeping with the predominance of 263 
erythroid CFUs in placental cells cultured from early gestation tissue [9].   However there is evidence 264 
that CD235a can mark hematopoietic stem cells [23] and the presence of CD41/integrin αIIb 265 
suggests that primitive cells might be able to progress into other blood cell lineages. This has 266 
previously been suggested in mouse [24, 25], but midgestation placental CD41+ cells could not 267 
reconstitute definitive hematopoiesis [26], so further investigation is warranted in human.  The 268 
details of erythroid maturation and its control are still to be worked out, but erythropoietin, a potent 269 
stimulator of erythroid lineage cells,  is produced by trophoblast, and a paracrine interaction has 270 
been demonstrated in which blocking PDGF signalling leads to upregulation of EPO and an increased 271 
erythroid cell population in the mouse placenta [27].  The data are consistent with the idea that the 272 
most active sites of erythroid initiation and maturation in human are in crypts adjacent to the 273 
trophoblast basement membrane.  Stromal (extravascular) erythroid cells were found to be 274 
associated with the later phases of HAF maturation at which cells start to dissociate, presumably for 275 
release into circulation. Such cells may be left behind after expulsion of the majority of cells from 276 
HAF into the vascular network, after which they are probably phagocytosed by Hofbauer cells, which 277 
are abundant in such areas.   Some pyrenocytes were detected, and it has been suggested that 278 
Hofbauer cells may ingest nuclei extruded from red blood cells originating either in the yolk sac or 279 
placenta [28].   However we tend to the supposition that most cells released from HAF into the 280 
embryonic circulation are nucleated.    281 
The expression of CD34 and brachyury (and some CD31 reactivity) is consistent with stem cells in 282 
these niches that retain the potential to produce endothelial (and probably other vascular) cells, 283 
hence we refer to the niche as a HAF.  The cell aggregates seem to undergo progressive loosening as 284 
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they join up with the vascular tree, eventually becoming incorporated entirely at 9-11 weeks.  They 285 
appear to open up progressively from the end proximal to the CP, ie the developing fetal circulation. 286 
This sequence of events does not occur at one specific time of gestation – rather it depends on the 287 
location, and in all probability the relationship with the onset of blood flow in that area. That is, 288 
various patterns of HAF morphology coexist in different locations in the villous placenta throughout 289 
the period 4-11 weeks.    Adherent, packed luminal cells characteristic of HAF seem to be cleared 290 
from the peripheral CP by 7 weeks, 2-3 weeks before they disappear from villi.  Placentally resident 291 
stem cells present later in gestation clearly occupy a different niche, and indeed scattered stromal or 292 
perivascular CD45+ cells have been observed [9, 29]. 293 
The supply of fetal erythrocytes may well be initiated from the yolk sac, but this is closely followed 294 
by the CP and villous placenta, the aortic-gonadal-mesonephric region, the liver and finally the bone 295 
marrow.   HAF contain cells expressing CD235a that also express high affinity fetal haemoglobin 296 
isoforms including Hbζ and Hbε [28].  They are red on inspection after delivery, and hence bear 297 
oxygen, though this could result from exposure to atmospheric oxygen.  However, they must bind 298 
oxygen tightly in the low partial pressure environment of the first trimester placenta.  Initially not in 299 
communication with the fetal circulation, the foci probably act as a reservoir of oxygen, gradually 300 
releasing oxygen-charged erythrocytes into the fetal circulation. The presence of erythroid foci in the 301 
CP and proximal/central villous placenta – sites closest to the cord -- means that this drip-feed of 302 
cells can start from the earliest stages of fetal circulatory connection.   Indeed in the rhesus 303 
macaque, intravillous circulation has been detected as early as 11 days after fertilisation [30]. We 304 
suggest more distal areas of the growing villous placenta are progressively incorporated.   305 
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Figure legends 
Fig 1 Flat-mounted fresh first trimester villi.  Note that bulbulotubal structures rich in hemoglobin 
extend inwards from sites immediately beneath the trophoblast. They are absent from some villi, for 
example the left hand branch in B.    They connect to presumptive channels that appear to lack 
hemoglobin.  Details of channel systems in A and B are shown in C and D respectively. Scale bars: A, 
25µm; B, 50µm; C, 15µm; D, 25 µm.  
Fig 2 Hemangioblastic foci (HAF) are readily identified in histological sections at (A) 4 and (B) 6 weeks 
(arrows), and a simple empty small vessel profile can be seen in a villus at 6 weeks (C, asterisk).  A is 
an archival specimen (H710) from the collection at the Centre for Trophoblast Research, Cambridge; 
the histological stain is unknown.  B and C are semithin resin sections stained with Toluidine blue.  
Note the elongated HAF extending from the edge towards the centre of the villous mesenchyme. 
The simple vascular channel shown in C is from a field adjacent to B.  Scale bars: A, 40 µm; B&C, 
5µm. 
Fig 3 Histology and lectin histochemistry of placenta and yolk sac reveals developing erythroid and 
endothelial cells in HAF.  (A) Several HAF profiles visible in a Toluidine blue-stained villus at 8 weeks.  
(B) At higher magnification, thin cells are visible at the periphery of a HAF. (C) Solanum tuberosum 
agglutinin (STA) staining of an adjacent section reveals various degrees of differentiation in the 
developing erythroid lineage, as well as presumptive endothelium. (D) Archival specimen (H710; 
4mm CRL; Gomori’s reticulin stain with neutral red counterstain) from approximately 4 weeks, 
revealing that the microfibrillar matrix around developing HAF (*) is discontinuous. (E,F) Combining 
Ulex europaeus-1 agglutinin (UEA-1) staining with a hematoxylin counterstain reveals a 
discontinuous endothelium (8 weeks). (G,H, I) Yolk sac (6 weeks) stained with UEA-1 and 
counterstained with hematoxylin, demonstrating features of endothelial and erythroid development 
similar to those seen in placenta at the same stage.  (J) Phytolacca americana  agglutinin (PAA) 
Figure Legend
binding to a 4 week placental vessel (*) demonstrates endothelial cell heterogeneity. Scale bars: A, 
50µm; B,C and J, 25µm; D, 15µm; E&F, 10µm; G,H,I, 5µm. 
Fig 4 Histology of CP and stem villi, illustrating opening of vascular luminal spaces and release of cells 
from different parts of the placenta, 6-7 weeks.  (A)  A central area in the CP at about 6 weeks (CTR 
specimen H33, CRL 10mm) shows large vessels opening up. Note that in an adjacent stem villus, cell 
displacement from a putative HAF is occurring proximally to the CP (arrow).  Further away from the 
stem villus-CP junction, putative HAF are densely packed with cells (arrowheads).  However fixation 
quality limits the interpretation.  (B) This shows central CP and stem villus, also at 6 weeks; the 
arrows point to small open capillaries in the CP, while the arrowhead locates a vessel in a stem villus 
from which cells are being displaced, note again the initiation of displacement is from the direction 
of the CP.  (C) Peripheral CP at 6 weeks showing an elongated HAF containing tightly packed cells 
(arrows) near to the trophoblast epithelium; (D) peripheral villus at 7 weeks showing a HAF 
containing closely packed cells at various stages of differentiation; (E) central proximal villus at 7 
weeks showing a large vessel with open lumen containing cells including differentiated erythrocytes.  
(A) Archival pregnancy hysterectomy specimens, presumed H&E. (F,G) Two areas from an 8 week 
placenta showing erythroid cells in vascular spaces and adjacent areas of stroma. In F, arrows 
highlight Hofbauer cells in the stroma and in a vessel.   In G,  arrows identify pyrenocytes (red cell 
nuclei) both in stroma and vessels.  However most erythroid cells in both locations are nucleated. 
Note that vascular endothelium is thin and discontinuous in both fields.   (B-G) Toluidine blue-
stained semithin resin sections.  Scale bars: A, 125µm; B, 25µm; C, 10µm; D, 20µm; E-G, 25µm. 
Fig 5 Immunofluorescence of whole-mounted first trimester villous tissue using antibodies to 
CD235a and CD31.  Examples from 5.5 weeks (A-C) and 8 weeks (D-F).  A and E show CD235a, while B 
and F show CD31.  C and D are the respective false colour overlays. Scale bars: A (also B & C), 10µm; 
D (also E & F), 25µm.  In C a developing vessel is shown containing tightly packed CD235a-positive 
cells, and a discontinuous endothelium (dotted lines show gaps, while asterisks mark endothelialised 
segments). In D a HAF (asterisk) contains many CD235a-positive cells along with traces of CD31 
immunoreactivity, and is immediately adjacent to a developing network of CD31+ cords and vessels.  
CD235a+ cells appear to be forming into channel-like structures (asterisk in E) but these have not yet 
acquired an endothelium, nor have they become incorporated into the adjacent CD31+ vascular 
network. 
Fig 6 Immunohistochemistry of lineage markers in 4-8 week villi.  Antigens and gestational ages are 
shown.  Aand B are adjacent sections. CD34 (A, C), nestin (B) and FLK 1 (D) are present in endothelial 
cells of the HAFs (arrows), with FLK 1 also being found in cytotrophoblast cells. Brachyury positive  
cells are present in HAFs (E), some of which adhere to the wall of the vessel (arrow).   In F, CD45 is 
expressed by  a leucoyte in a HAF (arrows) and in G stromal macrophages are stained (arrow).  Tr = 
trophoblast. Scale bars: A (also B-F), 25µm; G, 75µm. 
Supplemental Fig 1. Serial sections of Toluidine blue-stained semithin sections of a 6 week villus.  
The red rectangle identifies a group of cells that shows 4 nuclei in the first image, but another 
nucleus appears in the third section.  The circle in image 9 surrounds an apparently anuclear cell that 
is revealed in image 10 as containing a small pyknotic nucleus that has been cut through by image 
11, while the triangle in image 11 around an anuclear profile contains a nucleus in image 12.  Scale 
bar: 10µm.  Contrast has been increased to maximise the clarity of nuclear profiles, as a result of 
which the surrounding stroma appears bleached. 
Supplemental Fig 2.  A vasculogenic site near the tip of a distal villus at 5 weeks.   This is a 
conventional fluorescence image of a flat mounted specimen stained with CD31, with all the vascular 
elements visible, though not all are in focus.  Note that cords are extending from an area at right, 
which is near the villus tip, towards a more proximal, well-vascularised angiogenic zone at left.  Scale 
bar: 15µm. 
Supplemental Fig 3.  A series of fluorescence planes from a 5 week villus whole mount preparation 
stained with CD34 to localise endothelial cells in vasculogenic sites, assembled into a movie 
(approximately 20 seconds).  
Supplemental Fig 4. Stills from the Z-stack series in Fig 3.  A: 3 seconds. CD34 positive vessel (arrow) 
positioned immediately below the cytotrophoblast layer (CT) though which the imaging plane 
passes. B: 7 seconds; Example of a blind-ending vessel (arrow.) C: 13 seconds. As the series moves 
deeper into the villus small CD34 positive structures (circled) can be identified that are physically 
isolated from, and do not join with, surrounding vessels. A vessel appears to branch in the direction 
of the trophoblast (arrow). CD34 (green), PI (red). Scale bar: 50µm (all images to same scale). 
Supplemental Fig 5. Whole mount immunofluorescence showing CD235a (green) and CD34 (red). 
Small HAF at 8 and 10 weeks show both CD34 and CD235a positivity but no colocalisation is 
detected. Note that CD34 also marks adjacent vascular networks. 
Supplemental Fig 6. Whole mount immunostaining with CD41/integrin αIIb (green) and CD31 (red).  
The 5, 7 and 10 week images show CD41 in the centre panel and CD31 in the right panel, with DAPI 
added to the colour images.  DAPI marks trophoblast most effectively.  The boxed area at 5 weeks is 
shown in two focal planes.   Asterisks mark non-endothelialised HAFs at 6 and 7 weeks.  At 5 and 10 
weeks most CD41+ cells are enclosed within vascular structures though the endothelium is not 
continuous (eg white dotted line at 5w, top left).   
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